Over-Expression of Cancerous Inhibitor of PP2A (CIP2A) in Bone Marrow Cells from Patients with a Group of High-Risk Myelodysplastic Syndromes

By Li Na   Abe Shinya   Kurata Morito   Abe-Suzuki Shiho   Onishi Iichiroh   Kirimura Susumu   Murayama Toshihiko   Hidaka Michihiro   Kawano Fumio   Kitagawa Masanobu  

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 399-407

Springer Publishing Company

Access to resources Recommend Favorite

Effect of DLK1 on tumorigenesis in CD34+CD38- bone marrow cells in myelodysplastic syndromes

By Zhang Wei   Shao Zonghong   Fu Rong   Wang Huaquan   Li Lijuan   Yue Lanzhu  

Oncology Letters, Vol. 6, Iss. 1, 2013-07 ,pp. : 203-206

Spandidos Publications

Access to resources Recommend Favorite

Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes

By Ueda Yasunori  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1450-1458

Informa Healthcare

Access to resources Recommend Favorite

Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines

By Birnbaum Tobias   Roider Julia   Schankin Christoph   Padovan Claudio   Schichor Christian   Goldbrunner Roland   Straube Andreas  

Journal of Neuro-Oncology, Vol. 83, Iss. 3, 2007-07 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite

Bone marrow hyaluronan and reticulin in patients with malignant disorders

By Sundström G.   Hultdin M.   Engström-Laurent A.   Dahl I.  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 618-623

Humana Press, Inc

Access to resources Recommend Favorite